Spesolimab in refractory paediatric acrodermatitis continua of Hallopeau, a case series
Journal of the European Academy of Dermatology and Venereology · 2025-06 · 39 (6)
DOI: 10.1111/jdv.20500 ↗Kurz gefasst
Leserbrief in der Zeitschrift Journal of the European Academy of Dermatology and Venereology, online erschienen am 16.12.2024. Verfasst von Liting Cai und 5 weiteren Autor:innen. Beteiligte Einrichtung: Dermatology Hospital of Southern Medical University, Guangzhou, China. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Dermatology Hospital of Southern Medical University, Guangzhou, China.
- Dermatology Hospital of Fuzhou, Fuzhou, China.
ORCID-Profile: Liting Cai, Junjie Lin, Xinyan She
Zitieren
APA
Cai, L., Yan, Y., Li, Y., Lin, J., She, X., & Wang, X. (2025). Spesolimab in refractory paediatric acrodermatitis continua of Hallopeau, a case series. Journal of the European Academy of Dermatology and Venereology, 39(6). https://doi.org/10.1111/jdv.20500
Vancouver
Cai L, Yan Y, Li Y, Lin J, She X, Wang X. Spesolimab in refractory paediatric acrodermatitis continua of Hallopeau, a case series. Journal of the European Academy of Dermatology and Venereology. 2025;39(6). doi:10.1111/jdv.20500
BibTeX
@article{Cai2025,
author = {Cai, Liting and Yan, Yunling and Li, Yang and Lin, Junjie and She, Xinyan and Wang, Xiaohua},
title = {Spesolimab in refractory paediatric acrodermatitis continua of Hallopeau, a case series},
journal = {Journal of the European Academy of Dermatology and Venereology},
year = {2025},
volume = {39},
number = {6},
doi = {10.1111/jdv.20500}
}
EUVIMED